BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8619365)

  • 1. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
    Narusawa K; Nakamura T; Suzuki K; Matsuoka Y; Lee LJ; Tanaka H; Seino Y
    J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F; Lang K; Dony C; Kling L
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats.
    Bagi CM; Brommage R; Deleon L; Adams S; Rosen D; Sommer A
    J Bone Miner Res; 1994 Aug; 9(8):1301-12. PubMed ID: 7526611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy.
    Murakami H; Nakamura T; Tsurukami H; Abe M; Barbier A; Suzuki K
    J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
    Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT
    J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats.
    Bagi CM; DeLeon E; Brommage R; Adams S; Rosen D; Sommer A
    Bone; 1995 Apr; 16(4 Suppl):263S-269S. PubMed ID: 7542899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
    Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
    Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats.
    Bourrin S; Ammann P; Bonjour JP; Rizzoli R
    Endocrinology; 2000 Sep; 141(9):3149-55. PubMed ID: 10965885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck.
    Bagi CM; DeLeon E; Brommage R; Rosen D; Sommer A
    Calcif Tissue Int; 1995 Jul; 57(1):40-6. PubMed ID: 7545533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats.
    Lepola VT; Kippo K; Hannuniemi R; Laurén L; Virtamo T; Osterman T; Jalovaara P; Sellman R; Väänänen HK
    J Bone Miner Res; 1996 Oct; 11(10):1508-17. PubMed ID: 8889851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
    Wang W; Iresjö BM; Karlsson L; Svanberg E
    Clin Nutr; 2000 Apr; 19(2):127-32. PubMed ID: 10867731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
    Boonen S; Rosen C; Bouillon R; Sommer A; McKay M; Rosen D; Adams S; Broos P; Lenaerts J; Raus J; Vanderschueren D; Geusens P
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
    Cui L; Wu T; Liu YY; Deng YF; Ai CM; Chen HQ
    Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth and sexual function. Evidence that such treatment does not affect sexual maturation of fertility.
    Gruaz NM; d'Allèves V; Charnay Y; Skottner A; Ekvärn S; Fryklund L; Aubert ML
    Endocrine; 1997 Feb; 6(1):11-9. PubMed ID: 9225110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of progesterone on serum levels of IGF-1 and on femur IGF-1 mRNA in ovariectomized rats.
    Barengolts EI; Kouznetsova T; Segalene A; Lathon P; Odvina C; Kukreja SC; Unterman TG
    J Bone Miner Res; 1996 Oct; 11(10):1406-12. PubMed ID: 8889839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats.
    Bagi C; van der Meulen M; Brommage R; Rosen D; Sommer A
    Bone; 1995 May; 16(5):559-65. PubMed ID: 7544602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats.
    Sundström K; Cedervall T; Ohlsson C; Camacho-Hübner C; Sävendahl L
    Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats.
    Iwamoto J; Yeh JK; Takeda T
    J Bone Miner Res; 2003 Apr; 18(4):776-83. PubMed ID: 12674339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.